Expert Perspectives on the Management of Chronic Myeloid Leukemia

Expert Perspectives on the Management of Chronic Myeloid Leukemia

Episodes

Specialty:

All

Year:

All

EP. 1: Mutation Analysis in Chronic Myeloid Leukemia

January 14th 2016

EP. 2: Clinical Goals of Treating CML

January 14th 2016

EP. 3: Upfront Treatment of Chronic Myeloid Leukemia CML

January 14th 2016

EP. 4: Measuring Response in Chronic Myeloid Leukemia Treatment

January 14th 2016

EP. 5: Importance of Monitoring Patients with Chronic Myeloid Leukemia

January 14th 2016

EP. 6: Bone Marrow Assessment in CML Management

January 14th 2016

EP. 7: Chronic Myeloid Leukemia Treatment Discontinuation

January 14th 2016

EP. 8: Managing Toxicities from CML Treatment

January 14th 2016

EP. 9: Switching Therapy in Chronic Myeloid Leukemia

January 14th 2016

EP. 10: Stem Cell Transplant in Chronic Myeloid Leukemia

January 14th 2016

EP. 11: Case Study: Selecting a Tyrosine Kinase Inhibitor in CML

January 14th 2016

EP. 12: Closing Thoughts on Managing Chronic Myeloid Leukemia

January 14th 2016

Trending on OncLive

FDA Receives BLA for Etentamig in R/R Multiple Myeloma

Breaking Down Key Lung Cancer Data at ESMO 2026 With Drs Santos and Halmos

Basser Center for BRCA Awards 2026 Global Prize to Judy Garber

Sac-TMT Plus Pembrolizumab Improves PFS in PD-L1–Negative Nonsquamous NSCLC

Petosemtamab Plus Pembrolizumab Hits Phase 3 OS, ORR Primary End Points in PD-L1+ R/M HNSCC